Is a Second Wave coming?
Week Ahead – Market Recovery Under Threat?
Coronavirus pharma news roundup – 12/06/20
Futures Soar In Sharp Rebound From Thursday's Massacre
How stimulus dollars are spent will affect emissions for decades
S&P Futures Jittery, Nasdaq Surge Continues Ahead Of Fed Decision
Economic Collapse Has Turned Many Europeans against the EU
Quant-Quake Continues: Momentum Melts Down As Stocks & Bonds Rally
Platts: 4 Commodity Charts To Watch This Week
Watchdog Aims for Speedy Remdesivir Approval
Global Stocks Rise, S&P Futures Above 3,200 As Melt-Up Continues
Futures Jump Above 3,200; Brent Surges As Dollar Selling Accelerates
Bold Climate Stimulus By The E.U. To Have Major Impact
Emergence from lockdown gives equities a boost
After coronavirus, another hidden respiratory disease lurks in the buildings we left behind
Quo vadis, BTPs?
The EU delivers a fiscal stimulus package, EUR/USD back above 1.1000 – 1.1200 soon?
Grizzly On Equity Short Sellers And EU Regulations
New remdesivir study leaves clinicians guessing about its efficacy
FDA approval for Brilinta, EU recommendation for Lynparza
US Dollar Losses are Extended, but Momentum Stalls in the European Morning
June Starts with a Bang
Month-End Profit-Taking Weighs on Equities as the Euro Pops Above $1.11
Asia Booking Profits Ahead of the Weekend
Vietnam: a bright star in the COVID-19 dark sky
Escalating Tensions, Calm Markets
Coronavirus – Weekly update – 27 May 2020
General Electric Surges 8% Amid Sale Of Lighting Unit To Savant